Skip to main content
. 2021 May 14;41(2 Suppl 1):S90–S101. doi: 10.14639/0392-100X-suppl.1-41-2021-09

Table I.

Severity classification in Graves’ Orbitopathy, recommendations and levels of evidence (from EUGOGO 10).

Classification Recommendation Level of evidence
Sight-threatening GO: DON and/or corneal breakdown Immediate intervention IV, C
Moderate-to-severe GO: eye disease with sufficient impact on daily life (lid retraction ≥ 2 mm, exophthalmos ≥ 3 mm, moderate or severe soft tissue involvement) Active: immunosuppression
Inactive: surgical intervention
IV, C
Mild GO: minor impact on daily life (minor lid retraction< 2 mm, exophthalmos < 3 mm, mild soft tissue involvement, transient or no diplopia, corneal exposure responsive to lubricants) Local measures to alleviate symptoms IV, C

DON: Dysthyroid Optic Neuropathy; GO: Graves’ Orbitopathy.